Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey.

Pavlenko E, Barbova A, Hovhannesyan A, Tsenilova Z, Slavuckij A, Shcherbak-Verlan B, Zhurilo A, Vitek E, Skenders G, Sela I, Cabibbe AM, Cirillo DM, de Colombani P, Dara M, Dean A, Zignol M, Dadu A.

Int J Tuberc Lung Dis. 2018 Feb 1;22(2):197-205. doi: 10.5588/ijtld.17.0254.

PMID:
29506617
2.

Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience.

Sinkou H, Hurevich H, Rusovich V, Zhylevich L, Falzon D, de Colombani P, Dadu A, Dara M, Story A, Skrahina A.

Eur Respir J. 2017 Mar 22;49(3). pii: 1602049. doi: 10.1183/13993003.02049-2016. Print 2017 Mar. No abstract available.

3.

Framework for Selecting Best Practices in Public Health: A Systematic Literature Review.

Ng E, de Colombani P.

J Public Health Res. 2015 Nov 17;4(3):577. doi: 10.4081/jphr.2015.577. eCollection 2015 Nov 17. Review.

4.

High time to use rapid tests to detect multidrug resistance in sputum smear-negative tuberculosis in Belarus.

Rusovich V, Kumar AM, Skrahina A, Hurevich H, Astrauko A, de Colombani P, Tayler-Smith K, Dara M, Zachariah R.

Public Health Action. 2014 Dec 21;4(4):243-8. doi: 10.5588/pha.14.0069.

5.

Social determinants and risk factors for tuberculosis in national surveillance systems in Europe.

de Colombani P, Hovhannesyan A; Wolfheze Working Group on Social Determinants of TB and Drug Resistant TB.

Public Health Action. 2015 Sep 21;5(3):194-201. doi: 10.5588/pha.15.0026.

6.

Do incentives improve tuberculosis treatment outcomes in the Republic of Moldova?

Ciobanu A, Domente L, Soltan V, Bivol S, Severin L, Plesca V, Van den Bergh R, Kumar AM, de Colombani P.

Public Health Action. 2014 Oct 21;4(Suppl 2):S59-63. doi: 10.5588/pha.14.0047.

7.

Treatment outcomes among drug-susceptible tuberculosis patients in Latvia, 2006-2010.

Lucenko I, Riekstina V, Perevoscikovs J, Mozgis D, Khogali M, Gadoev J, de Colombani P, Kumar AM.

Public Health Action. 2014 Oct 21;4(Suppl 2):S54-8. doi: 10.5588/pha.14.0040.

8.

Risk factors associated with loss to follow-up among multidrug-resistant tuberculosis patients in Georgia.

Kuchukhidze G, Kumar AM, de Colombani P, Khogali M, Nanava U, Blumberg HM, Kempker RR.

Public Health Action. 2014 Oct 21;4(Suppl 2):S41-6. doi: 10.5588/pha.14.0048.

9.

Poor treatment outcomes among multidrug-resistant tuberculosis patients in Gomel Region, Republic of Belarus.

Khaliaukin A, Kumar AM, Skrahina A, Hurevich H, Rusovich V, Gadoev J, Falzon D, Khogali M, de Colombani P.

Public Health Action. 2014 Oct 21;4(Suppl 2):S24-8. doi: 10.5588/pha.14.0042.

10.

Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study.

Gadoev J, Asadov D, Tillashaykhov M, Tayler-Smith K, Isaakidis P, Dadu A, de Colombani P, Gudmund Hinderaker S, Parpieva N, Ulmasova D, Jalolov A, Hamraev A, Ali E, Boom Mv, Hammerich A, Gozalov O, Dara M.

PLoS One. 2015 Jun 15;10(6):e0128907. doi: 10.1371/journal.pone.0128907. eCollection 2015.

11.

Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011.

Ulmasova DJ, Uzakova G, Tillyashayhov MN, Turaev L, van Gemert W, Hoffmann H, Zignol M, Kremer K, Gombogaram T, Gadoev J, du Cros P, Muslimova N, Jalolov A, Dadu A, de Colombani P, Telnov O, Slizkiy A, Kholikulov B, Dara M, Falzon D.

Euro Surveill. 2013 Oct 17;18(42). pii: 20609.

12.

Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors.

Skrahina A, Hurevich H, Zalutskaya A, Sahalchyk E, Astrauko A, Hoffner S, Rusovich V, Dadu A, de Colombani P, Dara M, van Gemert W, Zignol M.

Bull World Health Organ. 2013 Jan 1;91(1):36-45. doi: 10.2471/BLT.12.104588. Epub 2012 Nov 26.

13.

Multidrug-resistant tuberculosis in Eastern Europe: still on the increase?

Migliori GB, Dara M, de Colombani P, Kluge H, Raviglione MC.

Eur Respir J. 2012 Jun;39(6):1290-1. doi: 10.1183/09031936.00214411. No abstract available.

14.

Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement.

Dara M, de Colombani P, Petrova-Benedict R, Centis R, Zellweger JP, Sandgren A, Heldal E, Sotgiu G, Jansen N, Bahtijarevic R, Migliori GB; Wolfheze Transborder Migration Task Force.

Eur Respir J. 2012 Nov;40(5):1081-90. doi: 10.1183/09031936.00053012. Epub 2012 May 31. Review.

15.

Exploring TB-Related Knowledge, Attitude, Behaviour, and Practice among Migrant Workers in Tajikistan.

Gilpin C, de Colombani P, Hasanova S, Sirodjiddinova U.

Tuberc Res Treat. 2011;2011:548617. doi: 10.1155/2011/548617. Epub 2012 Jan 19.

16.

WHO regional office for Europe: can tuberculosis be contained in the European Region?

Zaleskis R, Ditiu L, de Colombani P, Dadu A; World Health Organization Europe.

Eur J Public Health. 2007 Dec;17(6):668. No abstract available.

PMID:
18083757
17.

Low HIV infection rates among tuberculosis patients in Dhaka, Bangladesh.

Alam MS, Sarker MS, Mahmud AM, Faruq AK, Begum J, de Colombani P, Yirrell D, Sack DA, Azim T.

Int J STD AIDS. 2005 Jan;16(1):86-8. No abstract available.

PMID:
15705285
18.

European framework to decrease the burden of TB/HIV.

de Colombani P, Banatvala N, Zaleskis R, Maher D; WHO regional office for Europe.

Eur Respir J. 2004 Sep;24(3):493-501.

19.

Tuberculosis and patient gender in Bangladesh: sex differences in diagnosis and treatment outcome.

Begum V, de Colombani P, Das Gupta S, Salim AH, Hussain H, Pietroni M, Rahman S, Pahan D, Borgdorff MW.

Int J Tuberc Lung Dis. 2001 Jul;5(7):604-10.

PMID:
11467366
20.

Achievements of the National TB Control Programme.

Hoque MA, de Colombani P.

Bangladesh Med Res Counc Bull. 1999 Dec;25(3):71-82. No abstract available.

PMID:
11026938
21.

TB control in Bangladesh: more challenges ahead.

de Colombani P.

Bangladesh Med Res Counc Bull. 1999 Dec;25(3):51-4. No abstract available.

PMID:
11026936
22.

Tuberculosis and health sector reform in Bangladesh.

Kumaresan JA, de Colombani P, Karim E.

Int J Tuberc Lung Dis. 2000 Jul;4(7):615-21. Review.

PMID:
10907763
23.

Review of national tuberculosis programmes: the experience in Bangladesh.

Kumaresan JA, de Colombani P, Smith I.

Int J Tuberc Lung Dis. 1999 Dec;3(12):1140-2.

PMID:
10599021
24.

Post-emergency epidemiological surveillance in Iraqi-Kurdish refugee camps in Iran.

Babille M, De Colombani P, Guerra R, Zagaria N, Zanetti C.

Disasters. 1994 Mar;18(1):58-75.

PMID:
8044642

Supplemental Content

Loading ...
Support Center